These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 12183048
1. Effect of amphetamine repeated treatment on the feeding behavior in neuropeptide Y-overexpressing mice. Kuo DY, Inui A, Cheng JT. Neurosci Lett; 2002 Sep 06; 329(3):359-61. PubMed ID: 12183048 [Abstract] [Full Text] [Related]
2. Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression. Kuo DY. Behav Brain Res; 2003 Dec 17; 147(1-2):149-55. PubMed ID: 14659580 [Abstract] [Full Text] [Related]
3. Role of hypothalamic neuropeptide Y (NPY) in the change of feeding behavior induced by repeated treatment of amphetamine. Kuo DY, Hsu CT, Cheng JT. Life Sci; 2001 Dec 07; 70(3):243-51. PubMed ID: 12005258 [Abstract] [Full Text] [Related]
4. Evidence for the involvement of dopamine D(1) and D(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine. Chen TY, Duh SL, Huang CC, Lin TB, Kuo DY. J Biomed Sci; 2001 Dec 07; 8(6):462-6. PubMed ID: 11702009 [Abstract] [Full Text] [Related]
5. Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats. Hsieh YS, Yang SF, Chen PN, Chu SC, Chen CH, Kuo DY. J Psychopharmacol; 2011 Jul 07; 25(7):982-94. PubMed ID: 20817751 [Abstract] [Full Text] [Related]
6. Amphetamine-induced effects on neuropeptide Y in the rat brain. Obuchowicz E, Turchan J, Przewłocki R, Herman ZS. Pharmacol Rep; 2005 Jul 07; 57(3):321-9. PubMed ID: 15985714 [Abstract] [Full Text] [Related]
7. Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Gillard ER, Dang DQ, Stanley BG. Brain Res; 1993 Nov 19; 628(1-2):128-36. PubMed ID: 8313139 [Abstract] [Full Text] [Related]
8. Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice. Cannon CM, Abdallah L, Tecott LH, During MJ, Palmiter RD. Neuron; 2004 Oct 28; 44(3):509-20. PubMed ID: 15504330 [Abstract] [Full Text] [Related]
9. Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists. Kuo DY. Br J Pharmacol; 2006 Jul 28; 148(5):640-7. PubMed ID: 16702993 [Abstract] [Full Text] [Related]
10. NF-κB knockdown can modulate amphetamine-mediated feeding response. Kuo DY, Chen PN, Kuo MH, Chen CH, Hsieh YS, Chu SC. Neuropharmacology; 2012 Mar 28; 62(4):1684-94. PubMed ID: 22182781 [Abstract] [Full Text] [Related]
11. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression. Kuo DY, Chen PN, Yu CH, Kuo MH, Hsieh YS, Chu SC. Neuropharmacology; 2012 Oct 28; 63(5):842-50. PubMed ID: 22732442 [Abstract] [Full Text] [Related]
12. Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats. Hsieh YS, Chen PN, Yu CH, Chen CH, Tsai TT, Kuo DY. Neurotoxicology; 2015 May 28; 48():131-41. PubMed ID: 25825358 [Abstract] [Full Text] [Related]
13. Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y system. Obuchowicz E, Herman ZS. Pharmacol Rep; 2005 May 28; 57(6):850-5. PubMed ID: 16382207 [Abstract] [Full Text] [Related]
14. Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum. Hsieh YS, Yang SF, Kuo DY. Regul Pept; 2005 Apr 15; 127(1-3):169-76. PubMed ID: 15680483 [Abstract] [Full Text] [Related]
15. Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression. Hsieh YS, Yang SF, Chiou HL, Kuo DY. Toxicol Appl Pharmacol; 2006 Apr 15; 212(2):99-109. PubMed ID: 16084549 [Abstract] [Full Text] [Related]
16. Participation of ghrelin signalling in the reciprocal regulation of hypothalamic NPY/POMC-mediated appetite control in amphetamine-treated rats. Yu CH, Chu SC, Chen PN, Hsieh YS, Kuo DY. Appetite; 2017 Jun 01; 113():30-40. PubMed ID: 28229938 [Abstract] [Full Text] [Related]
17. Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats. Kuo DY. Regul Pept; 2005 Apr 15; 127(1-3):19-26. PubMed ID: 15680466 [Abstract] [Full Text] [Related]
18. Central dopamine action modulates neuropeptide-controlled appetite via the hypothalamic PI3K/NF-κB-dependent mechanism. Hsieh YS, Chen PN, Yu CH, Kuo DY. Genes Brain Behav; 2014 Nov 15; 13(8):784-93. PubMed ID: 25160767 [Abstract] [Full Text] [Related]
19. Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors. Schwendt M, McGinty JF. Neuroscience; 2010 Jun 16; 168(1):96-107. PubMed ID: 20298760 [Abstract] [Full Text] [Related]
20. Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats. Kuo DY. J Biomed Sci; 2002 Jun 16; 9(2):126-32. PubMed ID: 11914579 [Abstract] [Full Text] [Related] Page: [Next] [New Search]